AJ Ally, RPh, MBA
AJ Ally is Vice President for Argus Health. With responsibility for Clinical Strategy and programs, Mr. Ally oversees the company's clinical affairs, product development and management.
With more than 18 years' experience in the healthcare industry, Mr. Ally's deep understanding of the consumer and his insight into payer, provider and pharma motivations and drivers have led to the development of a number of new pharmacy management tools employed today.
A transformational leader and frequent speaker at national healthcare conferences on various topics in pharmacy benefit management, Mr. Ally has authored several industry publications and white papers. He also participated and helped earn the PBMI Pharmacy Innovation Award for CVS in 2012 and 2014.
Mr. Ally is a Registered Pharmacist and holds an M.B.A. from the State University of New York at Buffalo.
Sheila Arquette, RPH
Sheila Arquette is the current Executive Director at the National Association of Specialty Pharmacy and former Director of Pharmacy Services for Independent Health. She holds a Bachelor of Science in Pharmacy from the State University of New York at Buffalo School of Pharmacy. Sheila has extensive practical and leadership experience in retail and hospital pharmacy practice, LTC consulting and dispensing in addition to the managed care, PBM and specialty pharmacy space. She is a regular speaker and participant at national pharmacy conferences, roundtables and industry meetings and the author of several published articles.
Sheila serves as the as the Co-chair of the National Association of Specialty Pharmacy (NASP) Government Affairs Committee, was elected to the NASP Board of Directors and received the NASP Distinguished Service Award in September 2016. She is also is a long standing member of AMCP.
Steven G. Avey, RPh, MS, FAMCP,
Steven Avey is a distinguished expert in managed care and namesake of the Academy of Managed Care Pharmacy (AMCP) Foundation's prestigious lifetime achievement award, the Steven G. Avey Award. AMCP renamed their award in recognition of his achievements in quality measurement programs and improving drug assessment processes in the U.S. As Vice President of Specialty Programs at MedImpact, Steven is responsible for setting the overall business strategy in the specialty arena.
For the past 8 years, Steve has devoted his full attention to the appropriate management of specialty medications. His passion is working with clinicians and health outcomes researchers to better understand the value each specialty medication brings to a patient population and given their high cost, determine when and how they should be utilized. Due to the relatively small number of patients that must take a specialty medication, it leaves many opportunities for contracted pharmacies to directly influence the health status of these patients and better manage their care.
Steve began his career in retail practice, but following graduate school, managed care pharmacy became his focus. He initially started with Prospective Health (now Relay Health), where he helped establish and run its data services division. In 2000, after serving as treasurer and president of AMCP, he was hired as the executive director of the Foundation for Managed Care Pharmacy. This foundation presented education programs across the country training physicians and pharmacists how to better assess the value of new therapies. In 2005, Steve left AMCP to become Vice President of Managed Care at Partners Rx Management. Six years later he joined RegenceRx where we worked to assess the company's services, networks and rebates to determine how RegenceRx could better service its health plan.
In January 2013, Avey was named Vice President, Specialty Pharmacy Programs for MedImpact in San Diego, California. In this role, he is setting the overall clinical strategy in the specialty arena. His current title is Vice President Enterprise Specialty Clinical Solutions and he continues to work with clients ensuring the appropriate use of specialty therapies with high level clinical support programs through Medimpact Direct.
Steve holds a Bachelor of Science degree in pharmacy and a Master of Science degree in pharmacy administration from the University of Utah. He was named the College of Pharmacy's outstanding alumnus in 2003.
Gregory Daniel, PhD, MPH
Dr. Gregory Daniel, PhD, MPH is the Deputy Director of the Duke-Robert J. Margolis, MD Center for Health Policy and a Clinical Professor in Duke's Fuqua School of Business. Dr. Daniel directs the DC-based office of the Center and leads the Center's pharmaceutical and medical device policy portfolio, which includes developing policy and data strategies for improving development and access to innovative pharmaceutical and medical device technologies. This includes post-market evidence development to support increased value, improving regulatory science and drug development tools, optimizing biomedical innovation, and supporting drug and device value-based payment reform. Dr. Daniel is also Adjunct Associate Professor in the Division of Pharmaceutical Outcomes and Policy at the UNC Eshelman School of Pharmacy. Previously, he was Managing Director for Evidence Development & Biomedical Innovation in the Center for Health Policy and Fellow in Economic Studies at the Brookings Institution and Vice President, Government and Academic Research at HealthCore (an Anthem, Inc. company). In addition to health and pharmaceutical policy, Dr. Daniel'sresearch expertise includes real world evidence (RWE) development utilizing electronic health data in the areas of health outcomes and pharmacoeconomics, comparative effectiveness, and drug safety and pharmacoepidemiology. Dr. Daniel received a PhD in pharmaceutical economics, policy and outcomes from the University of Arizona, as well as an MPH, MS, and BS in Pharmacy all from The Ohio State University.
Leah King, PharmD, JD
Leah King is a lifelong resident of Pittsburgh, Pennsylvania, and can vouch for Pittsburgh’s status as one of the United States’ most livable cities. Leah’s current position is Manager of Pharmacy Strategy at Highmark Inc., with an emphasis on pharmacy vendor partnerships, commercial product pharmacy benefit strategy and specialty drug strategy. Prior to her role in pharmacy strategy, Leah served in a number of other capacities including clinical pharmacist in an inpatient hospital setting, corporate counsel for a Medicaid managed care and Medicare Advantage health plan and compliance consultant focusing on Medicare Part D and Medicare Secondary Payer requirements.
Leah holds a Doctor of Pharmacy (PharmD) from the University of Pittsburgh and a Juris Doctor (JD) from Duquesne University. She lives with her husband and two daughters, ages 4 and 2, in a suburb north of Pittsburgh.
Ruby Liu, BA, PharmD,
Ruby Liu, BA, PharmD, is the Director of Pharmacy at Alignment Healthcare (AHC), a healthcare services company focused on providing population health management services as a health plan and in partnership with health systems and provider groups around the country. Ruby oversees AHC's pharmacy benefit strategy, operations, and PBM oversight programs in multiple markets. In her current role, she implements strategies aimed at improving medication adherence, quality of care and HEDIS/Star programs, improving member experience with pharmacy benefit and managing drug expenditure trend.
Prior to her current role, Ruby served as a Subject Matter Expert at OptumRx, a UnitedHealth Group company, within the PBM's Formulary and Clinical departments and, also, managed a specialty pharmacy where she developed and implemented programs that improved medication adherence for geriatric patients and patients with HIV/AIDS.
Ruby holds a Bachelor of Arts degree from New York University and a Doctor of Pharmacy degree from the Arnold and Marie Schwartz College of Pharmacy.
Greg is a principal in the Global Human Resource Services (GHRS) practice at PwC and has more than 24 years of experience in the health and welfare benefit industry.
Greg specializes in working with clients on the strategy, assessment, and implementation of health and welfare benefits programs. Prior to joining PwC, he was a national leader in the health and welfare consulting practice of a major benefits consulting firm, responsible for specialized consulting services which included a pharmacy practice comprised of approximately 40 consultants serving Fortune 500 clients in pharmacy procurement, evaluation, and assessment engagements. Areas he focuses on include program strategy and design including medical, pharmacy, dental, wellness and other welfare programs, analytics of healthcare programs to understand cost drivers and opportunities to improve healthcare quality and outcomes, private health exchanges, including strategic assessments, vendor evaluations, negotiations, contracting, implementation and oversight, and evaluations of third party administrator performance, including program evaluation design and monitoring, performance guarantee reviews, and claim assessments.
Greg holds a BS in Economics from California State Polytechnic University, Pomona, and an MPH from the University of California at Los Angeles.
Ali McBride, PharmD, MS, BCPS,
Ali McBride is the Clinical Coordinator of Hematology/Oncology at The University of Arizona Cancer Center. He currently serves as Secretary of the Association of Community Cancer Centers (ACCC) and he has been actively involved with the American Society of Health-System Pharmacy (ASHP) currently serving as the Chair for the SAG on Emerging Sciences.
Dr. McBride has been working on oncology drug shortages and has testified on behalf of HOPA at FDA Drug Shortage Workshop, presented on behalf of ACCC at the Washington DC Congressional Session and was an invited member of the ASHP Drug Shortage Stakeholders Meeting. Dr. McBride is also actively involved with Biosimilar regulation and the pharmacoecomic impact of biosimilars into the US Marketplace. He currently serves as a working group member for HOPA on its biosimilar committee. In addition, he currently serves on the National Quality Forum Cancer Standing Committee. He has published numerous articles focussing on drug shortages, oral chemotherapy adherence, stem cell transplant and biosimilar implementation into the US health care market.
Donna Paine, PharmD, MBA
Donna is currently the Specialty pharmacy program manager with Blue Cross & Blue Shield of RI (BCBSRI). In this role she has responsibility for establishing formulary access, developing cost management and quality of care initiatives offered through the pharmacy program and creating provider-directed education and pharmacy performance incentive programs. Donna oversees the specialty pharmacy program that she implemented in 2008. Program components include use of preferred specialty pharmacy providers, clinical and utilization management services, and adoption of appropriate cost share design to support the benefit. This program served as a model for other health plans in optimizing the use of high cost biologics including drugs typically managed through the medical benefit. Donna is deeply involved with an initiative to consolidate medical and pharmacy specialty drug management and reconcile benefit discrepancies.
Donna received her Bachelor of Science degree in Pharmacy from the University of Rhode Island as well as her Masters in Business Administration. She later received her PharmD degree from the Massachusetts College of Pharmacy.
Meghan Pasicznyk, PharmD, MBA
Meghan Pasicznyk is Director of Specialty Market Development for Accredo, the Express Scripts specialty pharmacy. Meghan and her team develop products and programs designed to help payors reduce specialty drug spend and improve patient outcomes. Prior to her role in market development, she worked directly with large health plan clients to manage their specialty benefit. She has Doctorate of Pharmacy and Masters in Business Administration from Butler University in Indianapolis, Indiana.
Victoria Rodino is the Senior Manager for Virtual Health Programs at Children's Health. She has presented at international conferences on Virtual Health operations and strategy, and has collaborated on multiple published works around Telehealth initiatives within Children's Health, including Remote Patient Monitoring initiatives and leveraging technology to enhance access to care. Victoria is also a PhD candidate focused on leading change management and enhancing organizational effectiveness.
Bruce Rogen, MD MPH FACP
Dr. Bruce Rogen graduated from Brown University and then attended Tulane University Medical School for both his MD and MPH degrees, and completed his residency in general internal medicine at UCLA in 1991.
He worked with Kaiser Permanente in Los Angeles for many years as a board certified internal medicine specialist, including positions as assistant chief of medicine, director of hospital medicine, and director of utilization.
Since returning to his birthplace of Cleveland in 2009 he has been Chief Medical Officer for the 88,000 member Cleveland Clinic Employee Health Plan, while maintaining a small clinical practice.
Elizabeth Saltzman, PharmD
Elizabeth Saltzman graduated from the University of Michigan College of Pharmacy in 2012. She completed a PGY-1 Managed Care Pharmacy Residency with the University of Michigan/Blue Cross Blue Shield of Michigan program in 2013. After residency she became a clinical pharmacist on the Specialty Pharmacy team at Blue Cross Blue Shield of Michigan and is now Manager of Specialty Pharmacy Utilization Management. Dr. Saltzman manages the prior authorization program on the medical drug benefit as well as select specialty drugs, such as Hepatitis C, on the pharmacy benefit. One of her main roles is to oversee the process of specialty drugs going through the Pharmacy and Therapeutics Committee meeting.
Jeffrey Schmitt, RPh, BS, PharmD
Dr. Jeffrey Schmitt graduated from Duquesne University in 1989 with his Bachelors of Science in Pharmacy. After several years in the retail pharmacy setting, he obtained his Doctor of Pharmacy degree at the University of Pittsburgh in 1994. He then completed a Pharmacy Practice Residency at Hamot Medical Center in Erie, Pennsylvania, in 1995. Dr. Schmitt has worked for Highmark Blue Cross Blue Shield, Kaiser Permanente Health Plan of Ohio, and Employers Health, a national employer coalition headquartered in Canton, Ohio. Since 2009, he has served as the Director of Pharmacy for the Cleveland Clinic Employee Health Plan. He resides in Akron, Ohio, with his wife and three children.
Melissa Skelton Duke, PharmD, MS, BCPS,
Melissa Skelton Duke leads the specialty, home delivery, and ambulatory pharmacy service lines across Banner Health. Prior to joining Banner Health in April of 2014, Melissa led the development of clinical pharmacy services at Intermountain Healthcare, in Salt Lake City, Utah. Melissa has led the implementation and optimization of a number of clinical programs and quality initiatives in the acute care and ambulatory care arena-including the development of collaborative pharmacy practice agreements, antimicrobial stewardship programing, and professional development and competency assessment initiatives. In her role at Banner, she leads comprehensive specialty and home delivery programs, and develops and leads a variety of clinical and operational pharmacy programs in the ambulatory care space.
Melissa is also passionate about healthcare policy and professional engagement. She has held a number of elected and volunteer leadership positions at the state and national level, and is always eager to help others engage in the profession of pharmacy.
Neal S. Sofian
Neal is recognized nationally for almost 40 years of innovation in population-based and corporate health management/engagement, and organizational change. He is responsible for commercializing the first and now largest telephonic coaching programs in the United States during the 1980s, Free & Clear (now called Quit for Life) and many of the early health related social networking platforms including the American Cancer Society's Cancer Survivors Network.
He is a noted author and speaker and continues to be acknowledged as one of the true innovators in the world of health behavior change. Neal is currently the Director of Member Engagement at Premera Blue Cross where he is responsible for development strategies to engage the 2.2 million members of Premera in reaching their optimal health. He is focused on creating and implementing a model focused on personalized tailored messaging, rewards, and choice architecture based on creating segments of one.
Prior to Premera, Neal was the Director of Behavioral Interventions for Resolution Health after its acquisition of the NewSof Group of which Neal was the co-founder and CEO. The NewSof Group was a consulting and new media development company focused on scalable health change, learning, coaching, sharing, and support.
During his tenure at Group Health Cooperative, Neal served as Director of Innovation, Manager of Worksite and Community Programs, and General Manager of Health At Work, the Northwest's first worksite health promotion company in 1983. He designed health and productivity management services for regional and national employers incorporating health promotion, disease management, onsite primary care, and time loss management strategies.
He is a well-known author and speaker in the field of health management, humor and health, and the role of personalization and social networking. Neal holds a master's degree in public health from the University of Missouri School Of Medicine. He is also a working potter/sculpture and has done stand-up comedy in a vaudeville show.
Shelly Spiro, RPh, FASCP
Shelly Spiro is Executive Director of the Pharmacy HIT Collaborative (Collaborative). The Collaborative is an organization of the major national pharmacy associations and associate members focused on advocating and educating key stakeholders regarding the meaningful use of health IT and the inclusion of pharmacists within a technology-enabled integrated health care system. The goals of the Collaborative are to assure pharmacists' services through health IT are accessible, can connect, and support national quality initiatives. Spiro is active in national pharmacy associations, standards development organizations (NCPDP, HL7 and X12) and is a leader in Pharmacy HIT including 2014 appointment to Federal Advisory Committees Health IT Policy Committee's Interoperability and Health Information Exchange Workgroup. She is an American Society of Consultant Pharmacists (ASCP) Past President and 2014 Archambault Award recipient. She earned her BSPharm degree in 1976 from University of Illinois College of Pharmacy She has authored several articles and is a national speaker on topics relating to various professional pharmacy, HIT systems, terminology and electronic prescribing.
Eric Sredzinski, Pharm.D., AAHIVP
Dr. Eric Sredzinski is responsible for the Clinical Management, Disease State Management, training, and implementation of patient adherence and persistence programs for Avella Specialty Pharmacy. Working closely with the company's Oncology, Infectious Disease, and Transplant teams for presentations and business development, Dr. Sredzinski, a member of Avella Specialty Pharmacy's top management since joining the company in 2001, is also responsible for the management of manufacturer contracted data sets, including the participation in the development and testing of the data layout.
Graduating with a Doctor of Pharmacy degree from the University of Arizona College of Pharmacy (2000), Dr. Sredzinski focused his training in oncology/infectious disease. Following a pharmacy internship at Tucson Medical Center, he completed his pharmacy practice residency at the Southern Arizona VA Medical Center in Tucson, where he worked with the oncology team and the prostate and neurologic cancer department. Dr. Sredzinski worked as the clinical pharmacist for Arizona Oncology's autologous PSCT team where he assisted in the medication management of all pre and post-transplant patients.
Dr. Sredzinski is an active member of ASHP, The Arizona Pharmacists Association, HOPA, ASCO, and the AAHIVP. Dr. Sredzinski is currently involved in an NIH trial evaluating adherence and persistence in renal transplant patients that was recently presented at the American Transplant Congress and has been accepted for publication. Additional research in ADHD, the management of anticoagulated patients and trends in antidepressants, has been presented. Dr. Sredzinski currently presents to local, regional, and National organizations on a number of health topics, including adherence and persistence. Dr. Sredzinski is also active in community education, and has frequently presented to the HIV and Organ Transplant groups.
George Van Antwerp
George Van Antwerp is a leader within the pharmacy and PBM practice at Deloitte Consulting. George has worked in the pharmacy industry for over 15 years. He has designed, implemented, and managed numerous consumer engagement programs around retail to mail, therapeutic substitution, and adherence and worked on solutions for diabetes, oncology, opioid abuse, physician engagement, and utilization management. He has also worked on benefit design set- up, M&A, revenue cycle, and specialty pharmacy strategy projects.
Prior joining to Deloitte, George worked with inVentiv Health in their Medical Management business focusing on the TPA market. George also worked at Express Scripts where he focused on mail order and generic solutions and had prior consulting experience with Ernst & Young focused on the use of technology in the health plan sector. Additionally, he has worked with several health care start-ups in the consumer engagement and CRM space.
George holds an MBA and MArch from Washington University in St. Louis and received his BS from the University of Michigan in Ann Arbor. He has been quoted in the press frequently and presented at multiple conferences on different pharmacy topics. George is on the Board of Advisors for Cordant Health Solutions and the Board of Directors for Memory Care Home Solutions.